Cargando…
HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab
Characterization of the molecular mechanisms underlying antitumor immune responses and immune escape mechanisms has resulted in the development of more effective immunotherapeutic strategies, including immune checkpoint inhibitor (ICI) therapy. ICIs can induce durable responses in patients with adva...
Autores principales: | Ladányi, Andrea, Hegyi, Barbara, Balatoni, Tímea, Liszkay, Gabriella, Rohregger, Raphael, Waldnig, Christoph, Dudás, József, Ferrone, Soldano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073691/ https://www.ncbi.nlm.nih.gov/pubmed/35531074 http://dx.doi.org/10.3389/pore.2022.1610297 |
Ejemplares similares
-
Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma
por: Ladányi, Andrea, et al.
Publicado: (2020) -
The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients
por: Kispál, Mihály, et al.
Publicado: (2022) -
Breast Cancer Survivorship Programme: Follow-Up, Rehabilitation, Psychosocial Oncology Care. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kahán, Zsuzsanna, et al.
Publicado: (2022) -
The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator
por: Xu, Yanbo, et al.
Publicado: (2022) -
Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods
por: Liang, Zi-Qian, et al.
Publicado: (2022)